Ligand validation:4AB8

VXU: 3,4-dihydro-2H-1,5-benzodioxepin-6-ylmethanamine

VXU is a Ligand Of Interest in 4AB8 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4AB8_VXU_A_1253	52%	13%	0.127	0.883	0.94	3	-	6	1	0	100%	0.3

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.